Authors:
MIYOSHI Y
NAKAMURA H
TAGAMI T
SASAKI S
DORIN RI
TANIYAMA M
NAKAO K
Citation: Y. Miyoshi et al., COMPARISON OF THE FUNCTIONAL-PROPERTIES OF 3 DIFFERENT TRUNCATED THYROID-HORMONE RECEPTORS IDENTIFIED IN SUBJECTS WITH RESISTANCE TO THYROID-HORMONE, Molecular and cellular endocrinology, 137(2), 1998, pp. 169-176
Authors:
SHIMIZU F
FUKAGAWA M
YAMAUCHI S
TANIYAMA M
KOMEMUSHI S
MARGOLIN SB
KUROKAWA K
Citation: F. Shimizu et al., PIRFENIDONE PREVENTS THE PROGRESSION OF IRREVERSIBLE GLOMERULAR SCLEROTIC LESIONS IN RATS, Nephrology, 3(4), 1997, pp. 315-321
Authors:
TAKAMATSU N
KOJIMA M
TANIYAMA M
OHBA K
UEMATSU T
SEGAWA C
TSUTOU S
WATANABE M
KONDO J
KONDO N
SHIBA T
Citation: N. Takamatsu et al., EXPRESSION OF MULTIPLE ALPHA-1-ANTITRYPSIN-LIKE GENES IN HIBERNATING SPECIES OF THE SQUIRREL FAMILY, Gene, 204(1-2), 1997, pp. 127-132
Authors:
TANIYAMA M
KITAMURA K
BAN Y
SUGITA E
ITO K
KATAGIRI T
Citation: M. Taniyama et al., ELEVATION OF CIRCULATING PROADRENOMEDULLIN-N TERMINAL 20-PEPTIDE IN THYROTOXICOSIS, Clinical endocrinology, 46(3), 1997, pp. 271-274
Authors:
TANIYAMA M
KASUGA A
SUZUKI Y
OZAWA Y
HANDA M
KOBAYASHI A
BAN Y
Citation: M. Taniyama et al., ABSENCE OF ANTIBODIES TO ICA512 1A-2 IN NIDDM PATIENTS WITH THE MITOCHONDRIAL-DNA BP-3243 MUTATION/, Diabetes care, 20(5), 1997, pp. 905-906
Authors:
TANIYAMA M
OHBAYASHI S
NARITA M
NAKAZAWA R
HASEGAWA S
AZUMA N
TERAOKA S
OTA K
YAMAUCHI S
MARGOLIN SB
Citation: M. Taniyama et al., PHARMACOKINETICS OF AN ANTIFIBROTIC AGENT, PIRFENIDONE, IN HEMODIALYSIS-PATIENTS, European Journal of Clinical Pharmacology, 52(1), 1997, pp. 77-78
Authors:
TANIYAMA M
MORITA T
YAMAGISHI Y
KATO A
BANDO C
OKAWA N
KAJI A
Citation: M. Taniyama et al., HUMAN LYMPHOTOXIN MUTEIN LACKS HYPOTENSIVE ACTIVITY BUT HAS HIGHER IN-VIVO ANTITUMOR-ACTIVITY THAN LYMPHOTOXIN OR TUMOR-NECROSIS-FACTOR, Proceedings of the National Academy of Sciences of the United Statesof America, 94(7), 1997, pp. 3324-3329
Authors:
SUZUKI Y
IIZUKA T
KOBAYASHI T
NISHIKAWA T
ATSUMI Y
KADOWAKI T
OKA Y
KADOWAKI H
TANIYAMA M
HOSOKAWA K
Citation: Y. Suzuki et al., DIABETES-MELLITUS ASSOCIATED WITH THE 3243-MITOCHONDRIAL TRNA(LEU(UUR)) MUTATION - INSULIN-SECRETION AND SENSITIVITY, Metabolism, clinical and experimental, 46(9), 1997, pp. 1019-1023
Authors:
SUZUKI Y
GOTO Y
TANIYAMA M
NONAKA I
MURAKAMI N
HOSOKAWA K
ASAHINA T
ATSUMI Y
MATSUOKA K
Citation: Y. Suzuki et al., MUSCLE HISTOPATHOLOGY IN DIABETES-MELLITUS ASSOCIATED WITH MITOCHONDRIAL TRANSFER-RNA(LEU(UUR)) MUTATION AT POSITION-3243, Journal of the neurological sciences, 145(1), 1997, pp. 49-53
Authors:
TANIYAMA M
SUZUKI Y
MURATA C
SUGITA E
BAN Y
Citation: M. Taniyama et al., ALPHA-GLUCOSIDASE INHIBITOR (VOGLIBOSE) SAVES ENDOGENOUS INSULIN AND IMPROVES INSULIN SENSITIVITY, Diabetologia, 40, 1997, pp. 1212-1212
Authors:
MIYAOKA H
SUZUKI Y
TANIYAMA M
MIYAOKA Y
SHISHIKURA K
KAMIJIMA K
ATSUMI Y
MATSUOKA K
Citation: H. Miyaoka et al., MENTAL-DISORDERS IN DIABETIC-PATIENTS WITH MITOCHONDRIAL TRANSFER-RNA(LEU(UUR)) MUTATION AT POSITION-3243, Biological psychiatry, 42(6), 1997, pp. 524-526
Authors:
SHIMIZU F
FUKAGAWA M
TANIYAMA M
MARGOLIN SM
KUROKAWA K
Citation: F. Shimizu et al., PIRFENIDONE PREVENTS THE PROGRESSION OF IRREVERSIBLE GLOMERULAR SCLEROTIC LESIONS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 2590-2590
Authors:
TANIYAMA M
KUSANO S
MIYOSHI Y
NAKAMURA H
KAIHARA M
TOBE T
TOMITA M
KATAGIRI T
BAN Y
Citation: M. Taniyama et al., MILD RESISTANCE TO THYROID-HORMONE WITH A TRUNCATED THYROID-HORMONE RECEPTOR-BETA, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 104(4), 1996, pp. 339-343
Authors:
SUZUKI Y
HATA TR
MIYAOKA H
ATSUMI Y
KADOWAKI H
TANIYAMA M
KADOWAKI T
ODAWARA M
TANAKA Y
ASAHINA T
MATSUOKA K
Citation: Y. Suzuki et al., DIABETES WITH THE 3243-MITOCHONDRIAL TRNA(LEU(UUR)) MUTATION - CHARACTERISTIC NEUROIMAGING FINDINGS, Diabetes care, 19(7), 1996, pp. 739-743
Authors:
SUZUKI Y
MURAMATSU T
TANIYAMA M
ATSUMI Y
SUEMATSU M
KAWAGUCHI R
HIGUCHI S
ASAHINA T
MURATA C
HANDA M
MATSUOKA K
Citation: Y. Suzuki et al., MITOCHONDRIAL ALDEHYDE DEHYDROGENASE IN DIABETES-ASSOCIATED WITH MITOCHONDRIAL TRNA(LEU(UUR)) MUTATION AT POSITION-3243, Diabetes care, 19(12), 1996, pp. 1423-1425
Authors:
ONARI S
TANIYAMA M
ASAMI T
MATSUISHI K
ARAI T
Citation: S. Onari et al., RAMAN AND INFRARED-SPECTRA OF AMORPHOUS-SEMICONDUCTORS (GES2)(1-X)(BI2S3)(X) SYSTEMS, Journal of non-crystalline solids, 200, 1996, pp. 700-704
Authors:
TANIYAMA M
KITAMURA K
BAN Y
ETO T
KATAGIRI T
Citation: M. Taniyama et al., ELEVATED PLASMA ADRENOMEDULLIN LEVEL IN HYPERTHYROIDISM, European journal of clinical investigation, 26(6), 1996, pp. 454-456
Authors:
SUZUKI Y
KADOWAKI H
TANIYAMA M
KADOWAKI T
KATAGIRI H
OKA Y
ATSUMI Y
HOSOKAWA K
TANAKA Y
ASAHINA T
MOMIYAMA Y
MATSUOKA K
Citation: Y. Suzuki et al., INSULIN EDEMA IN DIABETES-MELLITUS ASSOCIATED WITH THE 3243-MITOCHONDRIAL TRNA(LEU(UUR)) MUTATION - CASE-REPORTS, Diabetes research and clinical practice, 29(2), 1995, pp. 137-142